'Xgeva 120mg belongs' presentation slideshows

Xgeva 120mg injection dose | Denosumab 120mg injection

Xgeva 120mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases.

126 views • 11 slides